Opportunities and challenges in the treatment of psoriatic arthritis

被引：10
作者：
FitzGerald, Oliver [1 ]
Ritchlin, Christopher [2 ]
机构：
[1] Univ Coll Dublin, St Vincents Univ Hosp, Conway Inst Biomol Res, Dublin, Ireland
[2] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Allergy Immunol & Rheumatol Div, Rochester, NY 14642 USA
来源：
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2018年 / 32卷 / 03期
关键词：
Psoriatic arthritis; Domains; Disease modification; Biologic agents; P40; MONOCLONAL-ANTIBODY; SEVERE PLAQUE PSORIASIS; RANDOMIZED PHASE-III; DOUBLE-BLIND; DISEASE-ACTIVITY; ANKYLOSING-SPONDYLITIS; CONTROLLED-TRIAL; RADIOGRAPHIC PROGRESSION; INADEQUATE RESPONSE; CLINICAL-EFFICACY;
D O I：
10.1016/j.berh.2019.03.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this chapter, we review the opportunities and challenges posed by the treatment options currently available in the treatment of psoriatic arthritis. Both established and new or emerging treatment options are discussed using a domain-based approach. Finally, approaches to how treatment can be optimized together with some clinical pearls are presented and discussed. With the increasing treatment options available, we need a better way of deciding which treatment should be considered for which patient. On the basis of current knowledge, some guidance is provided on how these choices might best be made. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码：440 / 452
页数：13
相关论文
共 69 条
  • [1] Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
    Antoni, C
    Krueger, GG
    de Vlam, K
    Birbara, C
    Beutler, A
    Guzzo, C
    Zhou, B
    Dooley, LT
    Kavanaugh, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) : 1150 - 1157
  • [2] Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparatore-controlled VOYAGE 1 trial
    Blauvelt, Andrew
    Papp, Kim A.
    Griffiths, Christopher E. M.
    Randazzo, Bruce
    Wasfi, Yasmine
    Shen, Yaung-Kaung
    Li, Shu
    Kimball, Alexa B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (03) : 405 - 417
  • [3] Psoriasis
    Boehncke, Wolf-Henning
    Schoen, Michael P.
    [J]. LANCET, 2015, 386 (9997) : 983 - 994
  • [4] Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
    Braun, Juergen
    Baraliakos, Xenofon
    Deodhar, Atul
    Baeten, Dominique
    Sieper, Joachim
    Emery, Paul
    Readie, Aimee
    Martin, Ruvie
    Mpofu, Shephard
    Richards, Hanno B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (06) : 1070 - 1077
  • [5] Magnetic Resonance Imaging Assessment of Axial Psoriatic Arthritis: Extent of Disease Relates to HLA-B27
    Castillo-Gallego, Concepcion
    Aydin, Sibel Z.
    Emery, Paul
    McGonagle, Dennis G.
    Marzo-Ortega, Helena
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (09): : 2274 - 2278
  • [6] Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis - A Department of Veterans Affairs cooperative study
    Clegg, DO
    Reda, DJ
    Mejias, E
    Cannon, GW
    Weisman, MH
    Taylor, T
    BudimanMak, E
    Blackburn, WD
    Vasey, FB
    Mahowald, ML
    Cush, JJ
    Schumacher, HR
    Silverman, SL
    Alepa, FP
    Luggen, ME
    Cohen, MR
    Makkena, R
    Haakenson, CM
    Ward, RH
    Manaster, BJ
    Anderson, RJ
    Ward, JR
    Henderson, WG
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (12): : 2013 - 2020
  • [7] Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis
    Coates, Laura C.
    Kavanaugh, Arthur
    Mease, Philip J.
    Soriano, Enrique R.
    Acosta-Felquer, Maria Laura
    Armstrong, April W.
    Bautista-Molano, Wilson
    Bochncke, Wolf -Henning
    Campbc, Willemina
    Cauli, Alberto
    Espinoza, Luis R.
    FitzGerald, Oliver
    Gladman, Dafna D.
    Gottlieb, Alice
    Helliwel, Philip S.
    Husni, M. Elaine
    Love, Thorvardur J.
    Lubrano, Ennio
    McHugh, Neil
    Nash, Peter
    Ogdie, Alexis
    Orbai, Ana -Maria
    Parkinson, Andrew
    O'Sullivan, Denis
    Rosen, Cheryl F.
    Schwartzman, Sergio
    Siege, Evan L.
    Toloza, Sergio
    Tuong, William
    Ritchlin, Christopher T.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68 (05) : 1060 - 1071
  • [8] Psoriatic arthritis: state of the art review
    Coates, Laura C.
    Helliwell, Philip S.
    [J]. CLINICAL MEDICINE, 2017, 17 (01) : 65 - 70
  • [9] Coates Laura C, 2010, J Rheumatol, V37, P448, DOI 10.3899/jrheum.090955
  • [10] Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors
    Deodhar, Atul
    Poddubnyy, Denis
    Pacheco-Tena, Cesar
    Salvarani, Carlo
    Lespessailles, Eric
    Rahman, Proton
    Jarvinen, Pentti
    Sanchez-Burson, Juan
    Gaffney, Karl
    Lee, Eun Bong
    Krishnan, Eswar
    Santisteban, Silvia
    Li, Xiaoqi
    Zhao, Fangyi
    Carlier, Hilde
    Reveille, John D.
    Antolini, Christopher
    Azevedo, Valderilio
    Barkham, Magnus
    Rodriguez, Aaron Alejandro Barrera
    Berman, Alberto
    Blicharski, Tomasz
    Brzezicki, Jan
    Burmester, Gerd
    Carrio, Judith
    Collantes, Eduardo
    Combe, Bernard
    Cons-Molina, Fidencio
    Cortes-Maisonet, Gregorio
    Dudek, Anna
    Barragan, Sergio Duran
    Elkayam, Ori
    Flint, Kathleen
    Galeazzi, Mauro
    Gaylis, Norman
    Goddard, David
    Fernandez, Carlos Gonzalez
    Goupille, Philippe
    Masmitja, Jordi Gratacos
    Greenwald, Maria
    Gremese, Elisa
    Hong, Seung Jae
    Howell, Mary
    Hrycaj, Pawel
    Ince, Akgun
    Ju, Ji Hyeon
    Kaine, Jeffrey
    Kang, Seong Wook
    Keiserman, Mauro
    Kim, Tae-Hwan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71 (04) : 599 - 611
1234567